INDRAYANI BIOTECH LTD.
Latest filings
- Rights Issue pre-issue advertisement published in newspapers · Compliance
- Indrayani Biotech Rights Issue: 5 for 7 at Rs 15, up to Rs 48.79 crores · Corporate Actions
- Indrayani Biotech revises Rights Issue schedule again · Corporate Actions
- New Company Secretary and Compliance Officer appointed · Management Changes
- Secretarial Auditor K. Ravichandran resigns due to personal reasons · Management Changes
- AGM extended till 30 Nov 2026; Rights Issue in pipeline · Board & Shareholder Meetings
- Newspaper publication of audited Q4 and FY26 results · Compliance
- Indrayani Biotech Q4 and FY26 audited results filed with qualified opinion · Results
- Indrayani Biotech FY26 results: auditor flags qualified opinion · Results
- Indrayani Biotech Q4 FY26: auditor gives qualified opinion on results · Results
- GST registration cancellation revoked; no impact on operations · Regulatory & Legal
- ITAT quashes tax order against Indrayani Biotech, matter remanded · Regulatory & Legal
- ITAT quashes tax order, sends case back for fresh hearing · Regulatory & Legal
- Compliance certificate for Q1 FY27 under SEBI Depositories Reg 74(5) · Compliance
- Trading window closed for Q1 FY27 results period · Compliance
- Indrayani Biotech postpones Rights Issue schedule indefinitely · Corporate Actions
- Resignation of Mrs. Ramya Ravi as the Company Secretary and Compliance Officer of the Company · Management Changes
- Annual Secretarial Compliance Report for the year ended 31st March, 2026 · Compliance
- Delay in financial results for the year ended 31st March, 2026 · Results
- Resignation letter of Mr. Indirakumar · Management Changes
- Outcome of the Rights Issue Committee Meeting held on 25th May, 2026 · Fund Raising
- Outcome of the Rights issue Committee Meeting held on 28-04-2026. · Fund Raising
- Company has received an IT Demand Notice · Regulatory & Legal
- Intimation of ISIN for Rights Entitlement to be credited for the purpose of Rights Issue of Indrayani Biotech Limited · Fund Raising
- Rights Issue of 3.25 Cr Partly Paid-Up Shares at ₹15 Each · Fund Raising
- Record date for the Partly Paid-up Rights Issue has been fixed as 28th April, 2026 · Corporate Actions
- Rights Issue of ₹49.90 Cr Approved at ₹15/Share · Fund Raising
- Outcome of the Board meeting held on 9th April, 2026 · Strategic Transactions
- Clarification provided on Price Movement · General
- The Exchange has sought clarification from Indrayani Biotech Ltd on April 8, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant .... · Regulatory & Legal
- The Company wishes to inform that a Meeting of the RIghts Issue Committee will be held on 9th April 2026 to approve some key parameters of the upcoming Rights Issue · Fund Raising
- The Company wishes to inform that a Meeting of the RIghts Issue Committee will be held on 9th April 2026 to approve some key parameters of the upcoming Rights Issue · Fund Raising
- Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/04/2026 ,inter alia, to consider and approve a proposal of demerger of .... · Strategic Transactions
- Compliance Certificate Under Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018, for the Quarter ended on 31st March,2026. · Compliance
- Intimation of Closure of Trading Window for the quarter ending 31st March,2026 · Compliance
- The Board of Directors of the Company at their meeting held on 24th March, 2026 has accepted the resignation of Mr. Indirakumar from the position of Whole-time Director of the Company · Management Changes
- The Board of Directors at their Meeting held today, discussed and accepted the Resignation of Mr. Indirakumar from the position of Whole-time Director with effect from the closing hours .... · Management Changes
- The Company hereby intimates the receipt of resignation letter from Whole-time Director Mr. Indirakumar (DIN:00892351). The resignation is pending formal acceptance and will be placed before .... · Management Changes
- Newspaper Publication for the unaudited financial results (Standalone and consolidated) for the Quarter ended December 31, 2025 · Compliance
- Resignation and Appointment of CFO of the Company · Management Changes
- Unaudited financial results (standalone and consolidated) for the Quarter ended 31st December 2025 · Results
- Outcome of the Board Meeting held on 26th February, 2026 for approval of the Unaudited financial results (Standalone and consolidated) for the Quarter ended 31st December, 2025 · Results
- Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/02/2026 ,inter alia, to consider and approve the unaudited financial results .... · Results
- Detailed reasons for delay in submission of unaudited financial results (Standalone & consolidated) for the quarter ended 31 st December 2025 · Results
- A Demand Notice paper publication has been issued to the Company by Hinduja Leyland Finance Limited for the default in outstanding term loan provided by them · Regulatory & Legal
- A Demand Notice paper publication has been issued to the Company by Hinduja Leyland Finance Limited for the default in outstanding term loan provided by them · Credit & Debt
- Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st December 2025 · Compliance
- Intimation of closure of trading window for the quarter ending 31st December, 2025 · Compliance
- Results for unaudited financial results for Quarter and Half year ended September 2025 · Results
- BSE has levied a fine on the Company due to non-submission of financial results for the Quarter ended 30th September, 2025, within the period as prescribed under Regulation 33 of SEBI LODR · Regulatory & Legal
Snapshot
What the business is, and whether it's a good one at a fair price.
A Agricultural Food & other Products company listed on BSE, reporting revenue of ₹138 Cr over the trailing twelve months.
Scorecard
Measured from the filed financials, judged against its Other Agricultural Products peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from INDRAYANI BIOTECH LTD.'s filed financials and exchange disclosures
What does INDRAYANI BIOTECH LTD. do?
INDRAYANI BIOTECH LTD. is a Agricultural Food & other Products company listed on BSE.
Is INDRAYANI BIOTECH LTD. profitable?
Yes. Over the trailing twelve months INDRAYANI BIOTECH LTD. reported a net profit of ₹2 Cr on revenue of ₹138 Cr.
Does INDRAYANI BIOTECH LTD. pay a dividend?
Not in the latest reported year — INDRAYANI BIOTECH LTD.'s dividend payout for FY26 was nil.
Is INDRAYANI BIOTECH LTD. debt-free?
No. Debt stands at 1.26× equity, and it carries net debt of ₹124 Cr. That is lower than 15% of its 54 Other Agricultural Products peers.
Is INDRAYANI BIOTECH LTD. expensive compared with its peers?
On trailing P/E, INDRAYANI BIOTECH LTD. ranks 52 of 65 in Other Agricultural Products — cheaper than 19% of them, against an industry median of 11.8×. This is a position, not a valuation judgement.
How much does the INDRAYANI BIOTECH LTD. share price move in a day?
On a typical session INDRAYANI BIOTECH LTD. moves 1.82% — that is the median absolute close-to-close move across its last 269 trading days. Announcement days are routinely larger.
Where can I track INDRAYANI BIOTECH LTD.'s announcements?
Every NSE and BSE filing by INDRAYANI BIOTECH LTD. appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.